3 assets in Diabetic Polyneuropathy

Therapeutic assets addressing Diabetic Polyneuropathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Duloxetine Diabetic Polyneuropathy	University of Rochester	P4	BB (71)
Pregabalin Diabetic Polyneuropathy	Syeda Khatoon e Jannat Welfare Foundation	P4	BB (71)
Adezunap Diabetic Polyneuropathy	Apurano Pharmaceuticals GmbH	P3	B (60)